Transasia Bio-Medicals wins Dual Honours at BW CFO World Best CFO & Finance Strategy Excellence Awards 2026
Aditi Pai Recognized with Gold and Silver Awards for Excellence in Wealth Creation and Balance Sheet Management Mumbai, India | June 2026: Transasia Bio-Medicals Ltd., India's leading in-vitro diagnostics company, is proud to announce that its
Aditi Pai Recognized with Gold and Silver Awards for Excellence in Wealth Creation and Balance Sheet Management
Mumbai, India | June 2026: Transasia Bio-Medicals Ltd., India’s leading in-vitro diagnostics company, is proud to announce that its Chief Financial Officer, Aditi Pai, has been honoured with two prestigious accolades at the 9th Edition of the BW CFO World Best CFO & Finance Strategy Excellence Awards 2026, recognizing outstanding financial leadership and strategic excellence.
The awards received include:
- Gold Award – Excellence in Sustained Wealth Creation
- Silver Award – Excellence in Healthy Balance Sheet ManagementThese recognitions underscore Transasia’s unwavering commitment to financial discipline, sustainable growth, and long-term value creation. The BW CFO World Awards are among the industry’s most respected recognitions, following a rigorous evaluation process that includes comprehensive performance assessments, extensive due diligence, and scrutiny by an eminent jury panel comprising leading business and finance experts.
Commenting on the achievement, Aditi Pai, CFO, Transasia Bio-Medicals Ltd., said:
“These awards are a reflection of the collective commitment, discipline, and dedication demonstrated across the organization. Sustainable wealth creation and prudent balance sheet management are outcomes of consistent execution, strong governance, responsible decision- making, and a shared vision for long-term growth. I am honoured to receive this recognition on behalf of the entire Transasia family.”
The recognition highlights Transasia’s robust financial stewardship and its ability to maintain a strong balance sheet while continuing to invest in innovation, expansion, and healthcare advancement. The company attributes this achievement to the trust and support of its promoters, leadership team, customers, employees, channel partners, and all stakeholders who have contributed to its growth journey.
At Transasia, financial excellence is deeply aligned with the company’s mission of advancing healthcare through innovative diagnostic solutions. The organization remains focused on building a future-ready enterprise that balances growth with responsibility while creating lasting value for all stakeholders.
Transasia Bio-Medicals extends its sincere gratitude to BW CFO World for this honour and acknowledges the presence of Shri Ashish Shelar, Hon’ble Minister for Information Technology and Cultural Affairs, Government of Maharashtra, who graced the occasion as Chief Guest.
As the company continues its journey of innovation, operational excellence, and sustainable growth, these recognitions serve as a strong validation of its long-term vision and commitment to creating meaningful impact in healthcare across India and global markets.
